Tous Actualités
Suivre
Abonner Biosafe Group

Biosafe Group

Biosafe introduces a brand new cell separator

Eysins (ots)

In line with its mission of market innovator, Biosafe is proud to announce the launch of the SepaMax multiprocessing device, on the occasion of the International Cord Blood Symposium in San Francisco.

SepaMax is designed for high throughput cell processing. Based on Biosafe's industry-leading Sepax technology, it offers six processing modules in a compact package, which are centrally controlled. Combined with a very cost-effective kit and protocol, SepaMax can process fully automatically up to 20 units / hour, making it very attractive for large scale cord blood bank production.

Olivier Waridel, CEO of Biosafe commented: "The new SepaMax device complements Biosafe's portfolio, offering quality, high throughput and automation in a single package. SepaMax is particularly suitable for large cord blood banks looking for high performance coupled with cost effectiveness. SepaMax is a brand new technology platform, which will host new applications for bioprocessing in the future as well".

About the Biosafe Group

Founded in 1997 the Biosafe Group is active in the design, manufacture and marketing of automated cell processing systems. Headquartered in Switzerland and privately-owned, the Biosafe Group operates through regional subsidiaries (Geneva, Houston, Hong-Kong, Shanghai and São Paulo) and is present in more than 50 countries, either directly or through distributors.

Contact:

For further information:
Christopher Bolton CFO Biosafe Group SA
+41-22-365-27-27
christopher.bolton@biosafe.ch www.biosafe.ch

Plus de actualités: Biosafe Group
Plus de actualités: Biosafe Group
  • 08.04.2014 – 07:00

    Biosafe achieves full registration in China

    Eysins, Switzerland (ots) - Biosafe is proud to report that it has just received the official registration of its single use disposable kits with the Chinese FDA. Following earlier approval of the Company's Sepax cell processing machine, Biosafe is now primed to launch sales of its products in the People's Republic of China. Olivier Waridel, CEO of the Biosafe Group commented: "We are the only company in our field which ...

  • 12.12.2013 – 07:00

    BIOSAFE targets Latin American expansion

    Eysins, Switzerland (ots) - Following the set-up of a Shanghai-based Chinese subsidiary and its recent expansion in India, Biosafe is demonstrating its firm commitment to emerging markets with the creation of a new subsidiary and the opening today of a new office covering the Latin American area. The new company, Biosafe do Brasil Participaçôes e Representações Ltda., based in the Vila Olímpia quarter of São Paulo ...

  • 28.10.2013 – 07:00

    BIOSAFE's latest innovation: Smart-Max

    Eysins, Switzerland (ots) - Biosafe is pleased to report the launch of its new Smart-Max device at the ESH World Cord Blood Congress in Monaco last week. The Smart-Max device has multiple areas of application in cell processing, including cell mixing, cooling, thawing, dilution, incubation and digestion. It is fully automated with an easy-to-use touchscreen interface and can handle bags of various sizes. Used in ...